Coq and Osteopenia - a phase IV clinical study of FDA data

Summary:

Osteopenia is reported as a side effect among people who take Coq (coenzyme q - 10), especially for people who are female, 50-59 old, also take Aredia, and have Metastases to bone.

The phase IV clinical study analyzes which people have Osteopenia when taking Coq. It is created by eHealthMe based on reports of 9,924 people who have side effects when taking Coq from the FDA, and is updated regularly.

What is Coq?

Coq has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 11,461 Coq users. Check the latest studies of Coq.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,469 drugs and 1,158 conditions by eHealthMe. Check the latest studies of Osteopenia.

On Feb, 16, 2026

9,924 people reported to have side effects when taking Coq.
Among them, 37 people (0.37%) have Osteopenia.

Among these 37 people:

What is the gender of people who have Osteopenia when taking Coq? *

female: 64.86 %
male: 35.14 %

What is the age of people who have Osteopenia when taking Coq? *

What are other drugs people take besides Coq? *

What are other side effects people have besides Osteopenia? *

Pain: 27 people, 72.97%
Stress And Anxiety: 26 people, 70.27%
Osteoporosis (bones weak and more likely to break): 23 people, 62.16%
Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 54.05%
Actinic Keratosis (skin disease due to sun exposure): 20 people, 54.05%
Chest Pain: 20 people, 54.05%
Intervertebral Disc Protrusion (spinal disc protrusion): 20 people, 54.05%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 19 people, 51.35%
Neoplasm Malignant (cancer tumour): 17 people, 45.95%
Injury: 17 people, 45.95%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 14 people, 37.84%
Multiple Myeloma (cancer of the plasma cells): 7 people, 18.92%
Prostatitis (inflammation of the prostate gland): 6 people, 16.22%
Osteoporosis (bones weak and more likely to break): 6 people, 16.22%
Hiv Infection: 5 people, 13.51%
Fatigue (feeling of tiredness): 4 people, 10.81%
Weakness: 3 people, 8.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.11%
Bone Pain: 3 people, 8.11%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Coq and have Osteopenia?

- Check whether Osteopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Coq:

Coq (11,461 reports)

Osteopenia treatments and more:

Osteopenia (46,944 reports)

Browse all side effects of Coq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteopenia:

Osteopenia (1,469 drugs)

Browse all the conditions that are associated with Osteopenia:

Osteopenia (1,158 conditions)

Related publications that referenced our studies

Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 (the active ingredients of Coq) and Coq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.